-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
scPharmaceuticals Inc. quarterly/annual Cost of Revenue history and growth rate from 2023 to 2024.
- scPharmaceuticals Inc. Cost of Revenue for the quarter ending March 31, 2024 was $1.79 M, a 195% increase year-over-year.
- scPharmaceuticals Inc. Cost of Revenue for the twelve months ending March 31, 2024 was $4.99 M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)